Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis.

Proceedings of the National Academy of Sciences of the United States of America
Tatiana KisselevaDavid A Brenner

Abstract

Myofibroblasts produce the fibrous scar in hepatic fibrosis. In the carbon tetrachloride (CCl(4)) model of liver fibrosis, quiescent hepatic stellate cells (HSC) are activated to become myofibroblasts. When the underlying etiological agent is removed, clinical and experimental fibrosis undergoes a remarkable regression with complete disappearance of these myofibroblasts. Although some myofibroblasts apoptose, it is unknown whether other myofibroblasts may revert to an inactive phenotype during regression of fibrosis. We elucidated the fate of HSCs/myofibroblasts during recovery from CCl(4)- and alcohol-induced liver fibrosis using Cre-LoxP-based genetic labeling of myofibroblasts. Here we demonstrate that half of the myofibroblasts escape apoptosis during regression of liver fibrosis, down-regulate fibrogenic genes, and acquire a phenotype similar to, but distinct from, quiescent HSCs in their ability to more rapidly reactivate into myofibroblasts in response to fibrogenic stimuli and strongly contribute to liver fibrosis. Inactivation of HSCs was associated with up-regulation of the anti-apoptotic genes Hspa1a/b, which participate in the survival of HSCs in culture and in vivo.

Associated Clinical Trials

References

Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·S L FriedmanD M Bissell
Nov 25, 1998·British Journal of Haematology·J P GoldmanA J Thrasher
Dec 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Vladimir V KalinichenkoRobert H Costa
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yutaka YataRichard A Rippe
Feb 21, 2004·Methods in Molecular Biology·Teresa S HawleyRobert G Hawley
Mar 30, 2004·Genesis : the Journal of Genetics and Development·Lore FlorinPeter Angel
Nov 13, 2004·The Journal of Biological Chemistry·Hongyun SheHidekazu Tsukamoto
Feb 4, 2005·The Journal of Clinical Investigation·Ramón Bataller, David A Brenner
Sep 24, 2005·Annals of the New York Academy of Sciences·Midori A YenariRona G Giffard
Dec 14, 2005·Alcoholism, Clinical and Experimental Research·Hide Tsukamoto
Apr 19, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sören V SiegmundRobert F Schwabe
Oct 24, 2007·Nature Medicine·Ekihiro SekiRobert F Schwabe
Mar 1, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rebecca G Wells
Mar 29, 2008·Methods in Molecular Biology·Hide TsukamotoAlla Dynnyk
Aug 30, 2008·Cell·Valery KrizhanovskyScott W Lowe
Dec 17, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kinji AsahinaHidekazu Tsukamoto

❮ Previous
Next ❯

Citations

Jun 29, 2013·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Anusha Hemamali TennakoonJyoji Yamate
Aug 8, 2012·Nature Medicine·Jeremy S Duffield
Mar 2, 2013·Nature Protocols·Adeline BertolaBin Gao
May 31, 2012·Proceedings of the National Academy of Sciences of the United States of America·Scott Laurence Friedman
Nov 2, 2012·Current Opinion in Rheumatology·Jelena Mann, Derek A Mann
Dec 1, 2012·Current Opinion in Rheumatology·Cécile Fligny, Jeremy S Duffield
Jan 11, 2013·Science Translational Medicine·Scott L FriedmanShelia Violette
May 3, 2013·The Journal of Clinical Investigation·Claus Kordes, Dieter Häussinger
May 3, 2013·The Journal of Clinical Investigation·Detlef Schuppan, Yong Ook Kim
May 3, 2013·The Journal of Clinical Investigation·Chunyue YinDidier Y R Stainier
Feb 26, 2013·The Journal of Clinical Investigation·Yong ZhouVictor J Thannickal
Apr 9, 2013·The Journal of Clinical Investigation·Gregory A MichelottiAnna Mae Diehl
Jan 4, 2013·Fibrogenesis & Tissue Repair·Katrien Van BenedenLeo A van Grunsven
Nov 28, 2013·Fibrogenesis & Tissue Repair·Christian LiedtkeRalf Weiskirchen
Jul 31, 2014·PloS One·Ya-Wei Liu, Yi-Tsau Huang
Oct 15, 2014·Nature Reviews. Cardiology·Huan WangKristi S Anseth
Jun 4, 2014·The Journal of Clinical Investigation·Jeremy S Duffield
Jul 31, 2014·Proceedings of the National Academy of Sciences of the United States of America·Keiko IwaisakoTatiana Kisseleva
Oct 25, 2012·Annual Review of Pathology·Jeremy S DuffieldThomas A Wynn
Aug 8, 2014·Nature Medicine·Stuart J Forbes, Nadia Rosenthal
Nov 12, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Yuan PengChenghai Liu
Dec 1, 2014·Current Pathobiology Reports·Agata PageJelena Mann
Jan 20, 2015·Current Pathobiology Reports·Rebecca G Wells
Nov 18, 2014·Current Pathobiology Reports·Keiko IwaisakoMasataka Asagiri
Nov 26, 2015·Current Pathobiology Reports·Jun XuTatiana Kisseleva
Jan 18, 2013·American Journal of Physiology. Cell Physiology·Gabriela CampanholleJeremy S Duffield
Mar 15, 2014·World Journal of Gastroenterology : WJG·Albert J Czaja
Nov 3, 2015·Drug Discovery Today·Paolo FagoneFerdinando Nicoletti
Jun 14, 2014·International Journal of Molecular Sciences·Tung-Hung SuChun-Jen Liu
Dec 31, 2014·Expert Opinion on Investigational Drugs·Peter HauffMatthias Ocker
Jan 23, 2016·Nature Reviews. Drug Discovery·Giovanni MussoRoberto Gambino
Jan 27, 2016·Experimental Cell Research·Akihiro YonedaYasuaki Tamura
Dec 12, 2012·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Fan-Chi ChangShuei-Liong Lin
Apr 29, 2015·International Journal of Cardiology·Christian G M van DijkCaroline Cheng
Jan 8, 2016·Toxicology and Applied Pharmacology·Pei-Jie ChenJun Li
Aug 28, 2014·Kidney International·Matthias Mack, Motoko Yanagita

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis